Results 161 to 170 of about 7,625,703 (311)

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Study on nutritional status and incidence of sarcopenia in elderly patients with chronic heart failure. [PDF]

Asia Pac J Clin Nutr
Song S, Du H, Lu X, Luo B, Li Z.
europepmc   +1 more source

Annual Report - Marine Biological Laboratory, 1934

, 1935
Annual report of the Marine Biological Laboratory in Woods Hole. 1934.
Marine Biological Laboratory (Woods Hole MA)
core  

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Hematology Laboratory Survey

Turkish Journal of Hematology, 2018
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit   +1 more
doaj   +1 more source

Evaluating a quality improvement learning collaborative: qualitative evaluation of Using Labs Wisely. [PDF]

BMJ Open Qual
Patey AM, Sivashanmugathas V, Hurwitz G, Weinerman A, Simons J, Levinson W.   +5 more
europepmc   +1 more source

Argonne National Laboratory Report ANL-4291

, 1949
Report issued by the Argonne National Laboratory discussing the progress and work completed between February and April, 1949. Descriptions of the studies conducted and progress made are presented.
Argonne National Laboratory, Brues, Austin M., Lisco, Hermann   +2 more
core  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

Molecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain, Yann Le Page, Frédéric Percevault, Emmanuelle Becker, Luc Negroni, Almudena Fernandez, Marta Cantero, Diego Muñoz‐Santos, Lluís Montoliu, Cyrille Garnier, Michael Primig   +10 more
wiley   +1 more source

Laboratory

American Journal of Public Health and the Nations Health, 1934
openaire   +3 more sources

The need to strengthen laboratory leadership, systems, and networks to enhance outbreak detection and resilience in Africa: proceedings of a regional workshop. [PDF]

BMC Proc
Onywera H, Njouom R, Wanjohi DW, Mushumbusi JPC, Moindze A, Kebede A, Ayitewala A, Mwafulango AE, von Gottberg A, Tanui CK, Shikaseba E, Moosa F, Koukouikila-Koussounda F, Guindo I, Ssewanyana I, Bitilinyu-Bangoh J, Nyandwi J, Ndlangisa KM, Koné KM, du Plessis M, Nyenje ME, Diagne MM, Mayet NT, Dereje N, Keita NY, Bonkoungou OJI, Mbala P, Akil-Bandali P, Essomba RG, Niama RF, Chilengi R, Mwangi S, Barro S, Moyo S, Nabadda SN, Maruta T, Muyigi T, Bitoungui VJN, Ahmad U, Chibabhai V, Mokaya WK, Tadjidine Y, Tessema SK, Kaseya J, Tebeje YK.   +44 more
europepmc   +1 more source